Moreover, in HNSCC, p70S6K is reportedly very active, and targeting it with rapamycin has a potential anti-tumor effect in vivo [139], possibly due to the activation of GSK3β. The gene discussed is GSK3B; the disease is head and neck squamous cell carcinoma.